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Abstract
Background: Although the clinical results of autologous chondrocyte implantation for articular
cartilage defects have recently improved as a result of advanced techniques based on tissue
engineering procedures, problems with cell handling and scaffold imperfections remain to be
solved. A new cell-sheet technique has been developed, and is potentially able to overcome these
obstacles. Chondrocyte sheets applicable to cartilage regeneration can be prepared with this cell-
sheet technique using temperature-responsive culture dishes. However, for clinical application, it
is necessary to evaluate the characteristics of the cells in these sheets and to identify their
similarities to naive cartilage.
Results: The expression of SOX 9, collagen type 2, 27, integrin α10, and fibronectin genes in triple-
layered chondrocyte sheets was significantly increased in comparison to those in conventional
monolayer culture and in a single chondrocyte sheet, implying a nature similar to ordinary cartilage.
In addition, immunohistochemistry demonstrated that collagen type II, fibronectin, and integrin α10
were present in the triple-layered chondrocyte sheets.
Conclusion: The results of this study indicate that these chondrocyte sheets with a consistent
cartilaginous phenotype and adhesive properties may lead to a new strategy for cartilage
regeneration.
Background
Osteoarthritis (OA), the most common articular disorder,
is characterized primarily by slow progressive degenera-
tion or destruction of cartilage. However, the exact etiol-
ogy of OA is not known. The symptoms of osteoarthritis
usually appear in middle age and almost everyone has
them by age 70. Therefore, adequate treatments for the
early stages of degeneration are required.
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Cartilage has two important functions, the reduction of
friction and the transmission of load. Some of the specific
properties of cartilage are a lack of blood vessels, a small
number of cell constituents, and a large amount of extra-
cellular matrix (ECM). Once cartilage has been damaged,
it is unable to heal itself.[1,2] There are various treatments
for damaged cartilage, but few recommended surgical pro-
cedures. Drilling, subchondral abrasion[3] and microfrac-
ture treatments[4] allow the regeneration of damaged
cartilage by activating mesenchymal stem cells derived
from the bone marrow; however, previous reports have
shown that the regenerated cartilage was fibrocartilage,
not hyaline cartilage. The functions and properties of
fibrocartilage are inferior to hyaline cartilage, and there-
fore the outcomes at long-term follow-up after these treat-
ments tend to be poor.[2] Mosaicplasty can be used to
transplant hyaline cartilage to the damaged area and
reports have shown at long-term follow-up that mosaic-
plasty is beneficial; however, it has associated donor site
morbidity, and only a predetermined defect area can be
treated.[5] The clinical results of arthroplasty for severe
osteoarthritis have improved with the development of
new surgical techniques and the selection of appropriate
medical devices. However, many obstacles have yet to be
overcome, including limited range of motion and durabil-
ity, and excessive invasiveness of the surgery. In addition,
resulting function is significantly inferior to that of the
normal joint. Therefore, the establishment of new proto-
cols for cartilage regeneration using tissue engineering is
important. Because of recent progress in tissue engineer-
ing, various techniques are available to cure damaged car-
tilage. Autologous chondrocyte implantation (ACI), first
reported by Brittberg et al., [6] has been used clinically.
Although clinical results show that this technique can be
beneficial, some problems remain, such as limits on the
size of lesions that can be treated, periostal hypertrophy,
and the lack of appropriate methods to evaluate the regen-
erated cartilage after ACI. Moreover, although the clinical
results of ACI have recently improved as a result of
advanced techniques based on tissue engineering proce-
dures, problems relating to cell handling and scaffold
imperfections remain. Artificial scaffolds have been
adopted to deliver cells into cartilage defect sites, and to
reinforce the mechanical stability of three-dimensional
tissue engineered chondral grafts. The ideal scaffold is
supposed to encourage ECM. Although, some scaffolds
have been successfully applied for the cartilage regenera-
tion,[7] there are problems with biocompatibility and cel-
lular viability, including cell attachment, distribution and
proliferation.
Recently, a cell-sheet technique[8] has been developed
that is potentially able to overcome these problems.
Therefore, a new strategy for cartilage regeneration with-
out a scaffold has been studied with cell-sheet technology
using temperature-responsive culture dishes (UpCell™
CellSeed Inc., Tokyo, Japan).
We previously reported[9] the implantation of layered
chondrocyte sheets, harvested by simply lowering the
temperature and with no need for enzyme digestion, in
Japanese white rabbits. We also verified the effectiveness
of chondrocyte sheets using a swine partial cartilage defect
model, which showed reduced degeneration. Interest-
ingly, in layered chondrocyte sheets, it appeared that cat-
abolic factors such as MMP3, MMP13, and ADAMTS5
decrease at the point of layering, while the expression of
TIMP1, an inhibitor of MMP3, increases.[9] This indicates
that layered chondrocyte sheets have fewer destructive fac-
tors than degenerate cartilage and have good adhesion
properties, which help to both protect and repair the car-
tilage surface.[9] However, the precise mechanisms by
which such chondrocyte sheets adhere to the damaged
cartilage and maintain the cartilage phenotype remain to
be elucidated. The purpose of this study was to further
investigate the properties of human chondrocyte sheets
using scanning electron microscopic evaluation and gene
expression and immunohistochemical analyses.
Results
Manipulation of chondrocyte sheets
Chondrocyte sheets prepared as either cell monolayer
sheets or three-layered sheets were obtained by simply
reducing the temperature, with no need for an enzymatic
digestion step (Fig. 1). The chondrocytes were harvested
as a single contiguous cell sheet, retaining the neighboring
extracellular structure, which implies that these cell sheets
should contain extracellular proteins including cell-cell
junction, ECM, and adhesion proteins.
The multilayered sheets could be easily produced by plac-
ing one chondrocyte sheet onto other sheets by making
use of the supporting PVDF membrane (Fig. 1A–C). By
repeating this procedure twice, three-layered cell sheets
were obtained (Fig. 1D). When cultured for 1 week, the
triple-layered chondrocyte sheets were extendable and
were not damaged by mild external force. This extended
multilayering process was sufficient to give a single contig-
uous multilayered structure in which each sheet had
adhered firmly and tightly to the other sheets.
With the help of the supporting membrane, the cell-sheet-
PVDF film showed good stability and we could easily han-
dle the chondrocyte sheets.
Scanning electron microscopy
SEM analysis revealed that the top and basal aspects of the
chondrocyte sheets showed completely different textures.
A network of laminated ECM structures was observed on
the top aspect of the sheet. These sheets of ECM structures
appeared piled up, with several sheet-like configurations
and amorphous shapes, and separated edges of the ECM
sheet occasionally being observed as dog-ears facing the
culture medium side (Fig. 2A).BMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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The surface of the basal aspect, which had been attached
to the bottom of the culture dish, was covered with a
smooth ECM pattern, and numerous humps (mound-like
elevations) were observed. Compared with the top side of
the chondrocyte sheet, the arrangement of the accumu-
lated ECM surface was smoother, with a parallel pattern
(Fig. 2B).
Analysis of gene expression
The expression of collagen type 1 (COL1) mRNA was
observed at significantly lower levels in the layered
chondrocyte sheets in comparison to the conventional
monolayer cultures and monolayer chondrocyte sheets
(Fig. 3A).
In contrast, the expression of collagen type 2 (COL2),
SOX9, COL 27, integrin α10 and fibronectin mRNAs were
observed at significantly higher levels in the layered
chondrocyte sheets in comparison to the conventional
monolayer cultures and monolayer chondrocyte sheets
(Fig. 3B–F).
Immunohistochemistry
Immunohistochemical examination revealed that
fibronectin, integrin α10, and COL2 were present in the
triple-layered chondrocyte cell sheet (Fig. 4). Interest-
ingly, fibronectin was located in the periphery of the tri-
ple-layered chondrocyte sheets. (Fig. 4A, D) and COL2
was observed in the pericellular matrix of the triple-lay-
ered chondrocyte sheets (Fig. 4B, E). However, in contrast
to these two proteins, integrin α10 was diffusely distrib-
uted throughout the triple-layered chondrocyte sheets
(Fig. 4C, F). These different immunohistochemical fea-
tures of target proteins are illustrated in Fig. 5, where the
main results are presented together.
Discussion
Cell-sheet technology using temperature-responsive cul-
ture dishes was first reported by Okano et al. in 1993.[8]
Since their report was published, this technology has been
studied with regard to regenerative medicine for the cor-
nea, heart, pancreas, and liver. [10-13] Nishida et al.
reported that corneal cell sheets cultured in temperature-
responsive culture dishes could strongly adhere to the cor-
nea without scaffolding or suturing.[10] Kushida et al.
reported that fibronectin expression was preserved on the
basal side of cell sheets cultured on temperature-respon-
sive culture dishes.[14] As cell sheets can be harvested
with the ECM and adhesion factors, it is simple to layer
the cell sheets one on top of another, using the natural
adhesiveness of the basal side. Therefore, large layered
three-dimensional tissues without a scaffold can be con-
structed in this repeating fashion. Shimizu et al. reported
that the maximum thickness of the fabricated rabbit myo-
cardial cell sheet is three layers in vitro because thicker
sheets receive inadequate nutrition. They also demon-
strated that repetitive allografts of cell sheets cannot
increase the thickness of the fabrication by more than 1
mm in myocardial tissues in vivo. [12]
To fabricate the multilayered sheets, we extended the cul-
ture by 1 week, which was effective enough to consolidate
the cell sheets into a single three-dimensional structure.
However, the cell sheets tended to float in the culture
medium because of their shape. Accordingly, it was neces-
sary to devise strategies to apply a physical force to the
sheets to enable them to attach gently to each other and
the bottom of dish during culture. Using cell-culture
inserts of an appropriate height and the weight of the cul-
ture-dish cover, we achieved an appropriately narrow
space to facilitate strong adhesion between the cell sheets.
Although our experimental study of allografts using lay-
Fabrication of the cell sheets Figure 1
Fabrication of the cell sheets. Temperature-responsive 
culture dishes on which chondrocytes had been cultured 
were removed from the incubator when the cells reached 
confluence and were let stand at about 25°C for 30 min (A). 
After the culture medium was removed, a polyvinylidene dif-
luoride (PVDF) membrane was put onto the dish (B), and the 
sheet was detached gently (C). The chondrocyte sheets 
could then be easily fabricated into multilayered constructs 
with the help of the PVDF and without the need for enzyme 
digestion (D).
Scanning electron microscopy Figure 2
Scanning electron microscopy. Scanning electron micro-
scopy revealed that the top (A) and the basal aspects (B) of 
the chondrocyte sheet demonstrated completely different 
textures. The chondron like texture was only observed on 
the basal aspect, which had adhesive properties. Scale bar = 
10 μm.BMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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ered chondrocyte sheets has been proceeding for only 2
months, good adhesion and an inhibitory effect on carti-
lage degeneration at injured sites has been confirmed
(unpublished data).
The SEM examination of the cell sheets indicated that the
top and the adhesive basal aspects were completely differ-
ent in texture. A network of laminated ECM was observed
on the top side of the sheets (Fig. 2A). These sheets of
ECM structure resemble the lamination of the normal
superficial cartilage zone, the "lamina splendens," as ini-
tially proposed by MacConaill and later identified by
Clark using SEM;[15] however, the scanning electron
micrographs show that the sheets do not have a smoother
surface than normal articular cartilage.[15] In this study,
it was impossible to observe a distinct collagen fibrous
structure, which may exist beneath the lamination.
According to scanning electron micrographs of ordinary
cartilage,[15] in the superficial zone several layers of col-
lagen fibrils exist immediately beneath the lamina splend-
ens, forming a mesh of interwoven fibrils that run parallel
to the articular surface, and the chondrocytes in this zone
appear to be located beneath the layers of collagen fibrils.
Meanwhile, on the basal aspect, numerous mound-like
elevations were observed in the surface with a texture sim-
ilar to an aggregation of chondron-like shapes. This
smoother surface more resembled normal cartilage sur-
face than did the top side of the cell sheets (Fig. 2B). The
flat and smooth surface of the basal aspect implies abun-
dant accumulation of extracellular proteins therein, and is
Relative expression of mRNA Figure 3
Relative expression of mRNA. The y-axis shows the mRNA expression relative to that of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). The results were evaluated using the SmartCycler II software program. GAPDH expression was 
used to normalize samples. The error bars represent the standard deviation. Type I collagen mRNA expression was present at 
a low level in the layered chondrocyte cell sheets (A). In contrast, type II collagen mRNA expression was at significantly higher 
levels in the layered chondrocyte sheets in comparison to the monolayer cultures and monolayer chondrocyte sheets (B). 
SOX9 and COL27 mRNA expression were observed at significantly higher levels in the layered chondrocyte sheets in compar-
ison to conventional monolayer cultures and monolayer chondrocyte sheets (C, D). Integrin α10 and fibronectin mRNA 
expression were at significantly higher levels in the layered chondrocyte sheets in comparison to the conventional monolayer 
cultures and the monolayer chondrocyte sheets (E, F).BMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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reflected in their characteristic adhesiveness. The flat bot-
toms of the culture dish and the effects of gravity during
the culture period may also fashion this even surface tex-
ture.
The concept of the chondron was first introduces by Ben-
ninghoff in 1925, with the chondrocyte and its pericellu-
lar capsules together representing the chondron,
historically considered the primary structural, functional,
and metabolic unit of articular and other hyaline carti-
lages.[16] During recent decades, many researchers have
investigated and established the molecular anatomy,
functional properties, and metabolic contribution of the
chondron in articular cartilage homeostasis and its failure
during the initiation and progression of degenerative oste-
oarthritis. It is interesting that SEM evaluations of the
basal aspect of the cell sheets suggest that chondrocytes
with ECM, chondrons, were embedded in opposing sides
of the sheet surfaces. Although chondrons were only
faintly observed because of the thick ECM, it is clear that
our sheets contain the basic structural, functional, and
metabolic units of articular cartilage and it is expected that
they will maintain their function of reduction of friction
and the transmission of load. It is thus suggested that,
using our technique, these triple-layered chondrocyte
sheets have substantially reconstructed the ordinary
superficial zone of articular cartilage. To our knowledge,
this is the first report of the morphologic evaluation of the
bottom aspect of cultivated chondrocytes, which was
made possible because the cell sheets were harvested as a
single contiguous shape using a noninvasive method
without enzyme digestion, thus keeping their original
structure.
In this study, the properties of the chondrocyte sheets
were investigated, including the expression and localiza-
Immunohistochemical examination: fluorescence microscopy of layered chondrocyte sheets Figure 4
Immunohistochemical examination: fluorescence microscopy of layered chondrocyte sheets. Fibronectin (shown 
in green) was detected in the periphery of the triple-layered chondrocyte sheets (A, D). However, collagen type II (shown in 
green) was located in the pericellular matrix of the triple-layered chondrocyte sheets (B, E) and integrin α10 (shown in green) 
was scattered diffusely throughout the triple-layered chondrocyte sheets (C, F). The blue color shows counterstained DNA. 
DAPI excites at about 360 nm and emits at about 460 nm when bound to DNA, producing a blue fluorescence. A, B, C: Scale 
bar = 20 μm. D, E, F: Scale bar = 2 μmBMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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tion of SOX9, COL1, 2, 27, integrin α10 and fibronectin.
SOX9 has recently been shown to be involved in the con-
trol of cell-specific activation of COL2A1 in chondrocytes
and to directly regulate the type II collagen gene in
vivo.[17] Therefore, the high mobility group protein SOX9
is emerging as a key regulator of chondrogenesis. Moreo-
ver, Jenkins et al. recently reported that the newest carti-
lage collagen gene, COL27A1, contains two enhancer
elements that bind SOX9.[18] Integrin α10 is specifically
expressed in chondrocytes. Chondrocytes, depending on
the species and tissue origin, express a characteristic set of
integrins, including receptors for collagen type II (α1β1,
α2β1, and α10β1), fibronectin (α5β1, αvβ3, αvβ5), and
laminin (α6β1). Among these receptors, integrin α10β1 is
the major integrin mediating chondrocyte-collagen inter-
actions in cartilage.[19,20] Compared with chondrocytes
in conventional monolayer culture and single chondro-
cyte sheets, the significantly higher expression of SOX9
and COL27 mRNA in the layered chondrocyte sheets
revealed characteristics more closely resembling normal
chondrocyte differentiation, which implies the mainte-
nance of a phenotype. In addition, significantly higher
expression of fibronectin and integrin α10 mRNA in the
layered chondrocyte sheets also demonstrated the adhe-
siveness of the cell sheets. Furthermore, on immunohisto-
chemical examination, the expression of fibronectin and
integrin α10 in the layered chondrocyte cell sheets veri-
fied this adhesiveness and illustrated the specific cartilag-
inous phenotype of the cell sheets. In both this study and
in earlier results using temperature-responsive sur-
faces[14] it was possible to recover monolayer cell sheets
together with deposited fibronectin. Fibronectin matrix
adhering to the basal side of cell sheets can function as a
glue to attach cell sheets onto other surfaces.[14] In fact,
cell sheets recovered from temperature-responsive sur-
faces easily adhere to other surfaces.[21] Interestingly, as
illustrated by the immunohistochemical results in this
study (Fig. 5), fibronectin was detected peripherally on
both sides of the triple-layered chondrocyte sheets, not
only on the basal aspect as described previously[14] but
also on the top side, while showing intense adhesiveness
on the basal side only. It is possible to hypothesize that
the culture period prolonged by 1 week with a cell-culture
Table 1: List of primers used in the real-time PCR.
Primer ID Accesion No. Sequence Expect size(bp)
Collagen Type 1-F NM_000088 AAG GGT GAG ACA GGC GAA CAA 170
Collagen Type 1-R TTG CCA GGA GAA CCA GCA AGA
Collagen Type II-F NM_033150 GGA CTT TTC TTC CCT CTC T 113
Collagen Type II-R GAC CCG AAG GGT CTT ACA GGA
SOX9-F NM_000346 AAC GCC GAG CTC AGC AAG A 138
SOX9-R CCG CGG CTG GTA CTT GTA ATC
Collagen27α1-F NM_032888 GGG CCT TAT GGA AAT CCA GGT C 176
Collagen27α1-R GGT CCA GGA TAG CCC TTG TGT C
Integrinα10-F NM_003637 CTG GGA TAT GTG CCC GTG TG 112
Integrinα10-R TTG GAG CCA TCC AAG ACA ATG A
Fibronectin1-F NM_001030524 GCA CAG GGG AAG AAA AGG AG 189
Fibronectin1-R TTG AGT GGA TGG GAG GAG AG
Schematic illustration of the distribution pattern of extracel- lular adhesion molecules in triple-layered chondrocyte sheets Figure 5
Schematic illustration of the distribution pattern of 
extracellular adhesion molecules in triple-layered 
chondrocyte sheets. Fibronectin was located peripherally 
in the triple-layered chondrocyte sheet and integrin α10 was 
observed close to the chondrocytes, in the pericellular 
matrix, in the layered construct. However, collagen type II 
was scattered diffusely throughout the layered cell sheets.BMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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Table 2: Results of the post hoc test (Scheffe's method).
Dependent variable (I) V1 (J) V1 Difference of averages (I-J) SEM P-value 95% CI Figure 3
Lower limit Upper limit
COL1 Mono Cell Sheet .05250 .05374 .635 -.1043 .2093
Layered .39500* .05374 .000 .2382 .5518 *1
Cell Sheet Mono -.05250 .05374 .635 -.2093 .1043
Layered .34250* .05374 .000 .1857 .4993 *2
Layered Mono -.39500* .05374 .000 -.5518 -.2382 *1
Cell Sheet -.34250* .05374 .000 -.4993 -.1857 *2
COL2 Mono Cell Sheet -.12750 .05183 .099 -.2787 .0237
Layered -.52500* .05183 .000 -.6762 -.3738 *3
Cell Sheet Mono .12750 .05183 .099 -.0237 .2787
Layered -.39750* .05183 .000 -.5487 -.2463 *4
Layered Mono .52500* .05183 .000 .3738 .6762 *3
Cell Sheet .39750* .05183 .000 .2463 .5487 *4
SOX9 Mono Cell Sheet .04500 .08833 .880 -.2127 .3027
Layered -.68500* .08833 .000 -.9427 -.4273 *5
Cell Sheet Mono -.04500 .08833 .880 -.3027 .2127
Layered -.73000* .08833 .000 -.9877 -.4723 *6
Layered Mono .68500* .08833 .000 .4273 .9427 *5
Cell Sheet .73000* .08833 .000 .4723 .9877 *6
COL27 Mono Cell Sheet -.13250 .17224 .751 -.6350 .3700
Layered -.43750 .17224 .088 -.9400 .0650 *7
Cell Sheet Mono .13250 .17224 .751 -.3700 .6350
Layered -.30500 .17224 .260 -.8075 .1975
Layered Mono .43750 .17224 .088 -.0650 .9400 *7
Cell Sheet .30500 .17224 .260 -.1975 .8075
Integrin a10 Mono Cell Sheet .05500 .10949 .883 -.2645 .3745
Layered -.36500* .10949 .027 -.6845 -.0455 *8
Cell Sheet Mono -.05500 .10949 .883 -.3745 .2645BMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
Page 8 of 11
(page number not for citation purposes)
insert may affect the localization of fibronectin. In this
period, the fibronectin could either be moved from its
position in the single-layer cell sheets or be newly secreted
in areas of contact with the insert. However, the exact
mechanism underlying this phenomenon is unclear in
our results and further research into this is required.
It is inevitable that for medical applications and when
using vital cells such as in ACI, preparation times, includ-
ing in vitro culture periods, will need to be shortened.
Overall, it is important to be able to reduce the chondro-
cyte culture time before cell-sheet harvesting, with
reduced time for cell expansion and ECM production, but
without changing the extra week of culture to reinforce the
cell sheets as this prolonged step is substantially beneficial
to this new strategy to cure OA using bioengineered
chondrocyte sheets.
In conventional ACI[6] for cartilage regeneration, trans-
planted periosteal patches, which are used to enclose the
implanted chondrocytes, sometimes cause hypertrophy of
the regenerated chondral surface. Some improved meth-
ods use alternative scaffolds such as collagen membranes,
hyaluronan polymers, and atelocollagen gels.[7,22] In
comparison to these conventional ACI techniques, the
cell-sheet technology has the specific advantage of gener-
ating three-dimensional tissues fabricated by autologous
cells without using a scaffold while also showing intense
adhesiveness on the basal side. The advantages of such cell
sheets are that it is easy to culture and expand, and, most
importantly, they have good adhesion and barrier func-
tion.[9] This means they can protect against intra-articular
catabolic factors and prevent proteoglycan escape from
the injured site. Moreover, these cell sheets are considered
to contain an advantageous supply of growth factors. Fur-
thermore, such cell sheets could be useful as an alternative
to the periosteum itself, which is usually used in ACI.
Although cell sheets have good adhesive properties com-
pared with other applications using cell-sheet techniques,
such as in the cornea and heart, transplanted chondrocyte
sheets will be exposed to a harsh environment resulting
from weight bearing and friction. Development of new
devices to prevent the sheets peeling from the trans-
planted site is indispensable to future clinical application.
Although focal gene delivery using a cell sheet has not
been addressed in this paper, this may also have clinical
potential for treatment of cartilage degeneration. The
development of a therapeutic apparatus to deliver the cell
sheet to the injured site less invasively may therefore be
fundamental to expanding its use in the treatment of
patients demonstrating the early stages of osteoarthritis.
The results of this study therefore lead to a new strategy for
cartilage regeneration using novel bioengineered
chondrocyte sheets produced using a cell-sheet technique.
Conclusion
These experiments demonstrated that triple-layered
chondrocyte sheets contain the phenotypic markers
COL2, COL27, SOX9, and the adhesion molecules
integrin α10 and fibronectin. Cell-sheet technology there-
fore provides particular advantages for cartilage regenera-
tion, giving three-dimensional tissue constructed without
a scaffold and with good adhesiveness to both itself and
to an injured cartilage site.
Methods
Preparation of human chondrocytes
This study was performed in compliance with the Helsinki
Declaration, and was approved by the Institutional
Review Board for Clinical Research of Tokai University
School of Medicine (ref. 04–056).
Human chondrocytes were obtained from the knee joints
of young athletes who underwent anterior cruciate liga-
Layered -.42000* .10949 .013 -.7395 -.1005 *9
Layered Mono .36500* .10949 .027 .0455 .6845 *8
Cell Sheet .42000* .10949 .013 .1005 .7395 *9
Fibronectin Mono Cell Sheet -.71500* .16992 .007 -1.2108 -.2192 *10
Layered -.93000* .16992 .001 -1.4258 -.4342 *11
Cell Sheet Mono .71500* .16992 .007 .2192 1.2108 *10
Layered -.21500 .16992 .479 -.7108 .2808
Layered Mono .93000* .16992 .001 .4342 1.4258 *11
Cell Sheet .21500 .16992 .479 -.2808 .7108
Table 2: Results of the post hoc test (Scheffe's method). (Continued)BMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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ment reconstruction at Tokai University Oiso hospital
from December 2004 to April 2006. Twenty-nine knees
from 29 patients aged 14 to 49 years (21 males and 8
females) were used as the source of these cells. All subjects
provided informed consent. The specimens were stored in
basal medium (BM) containing Dulbecco's modified
Eagle's medium/F12 (DMEM/F12; GIBCO, Invitrogen
Corporation, Carlsbad, CA, USA) supplemented with
10% heat-inactivated fetal bovine serum (FBS; GIBCO)
and 50 μg/ml ascorbic acid (Wako Pure Chemical Indus-
tries, Ltd, Osaka, Japan) and 1% antibiotic-antimycotic
mixture (ABAM; 10,000 U/ml penicillin G, 10,000 μg/ml
streptomycin sulfate, and 25 μg/ml amphotericin B as
Fungizone; GIBCO) until required for the next step. The
cartilage samples were cut into small pieces. Thereafter,
minced specimens were digested for 1 hr in BM contain-
ing 0.4% Pronase E (Kaken Pharmaceutical Inc., Tokyo,
Japan), and for a further 4 hrs in BM containing 0.016%
Collagenase P (Roche Diagnostics GmbH, Mannheim,
Germany). The digested cell suspension was passed
through a cell strainer (BD Falcon™; BD Bioscience, Bed-
ford, MA, USA) with a pore size of 100 μm, and the iso-
lated cells rinsed twice with chilled Dulbecco's phosphate-
buffered saline (PBS; Dainippon Pharmaceutical Co.,
Osaka, Japan). The chondrocytes were then seeded into
500 cm2 square dishes (245 × 245 mm; Corning Inc.,
Corning, NY, USA) at a density of 10,000 cells/cm2 and
cultured in BM with 20% FBS (GIBCO) at 37°C in an
atmosphere of 5% CO2 and 95% air (according to the
method of Sato et al.).[23]
Temperature-responsive culture dishes
The specific procedures for the preparation of tempera-
ture-responsive culture dishes (provided by CellSeed, Inc)
have all been previously described.[24] Briefly, N-isopro-
pylacrylamide (IPAAm) monomer solution was spread
onto commercial tissue-culture polystyrene dishes. These
dishes were then subjected to electron beam irradiation,
thus resulting in polymerization and covalent binding of
the IPAAm to the dish surface. Poly-IPAAm (PIPAAm)-
grafted dishes were rinsed with cold distilled water to
remove any ungrafted IPAAm. Finally, the culture dishes
were sterilized using ethylene oxide gas.
Preparation of conventional monolayer cultures of 
chondrocytes and single-layer chondrocyte sheets
To detach the primary passage cells, chondrocytes were
digested using 0.05% trypsin:EDTA (GIBCO), and then
counted using a hematocytometer. For the conventional
monolayer culture, cartilage cells were seeded into culture
dishes (diameter: 35 mm, Iwaki Glass Company, LTD.,
Tokyo, Japan) at a density of 1,000 cells/cm2. To prepare
the single-layer chondrocyte sheets, resuspended
chondrocytes were seeded at a density of 10,000 cells/cm2
in UpCell culture dishes (diameter: 35 mm, provided by
CellSeed, Inc.). The seeded chondrocytes were cultured in
BM adjusted to 20% FBS (GIBCO) at 37°C in an atmos-
phere of 5% CO2 and 95% air. At 100% confluence, the
cultured cells were harvested and prepared for gene
expression analysis.
The samples in conventional culture were harvested with
a sterile cell scraper. To release confluent cells as a monol-
ayer chondrocyte sheet from the UpCell temperature-
responsive culture dishes, the dishes were removed from
the incubator and let stand at about 25°C for 30 min. The
culture medium was then removed from the dish, and the
cell sheet harvested using polyvinylidene difluoride
(PVDF) membrane as a supporting membrane. The lifted
chondrocyte sheet edges promptly attached to the over-
laid supporting membrane, and the cell sheet and PVDF
membrane film were gently detached from the UpCell
dish.
Fabrication of cell sheet into three-layer sheets of 
chondrocytes
Each cell sheet prepared as above was transferred onto
another confluent chondrocyte sheet to fabricate multi-
layered sheets. Because the multilayered sheets spontane-
ously floated in culture medium, a 0.4 μm cell culture
insert (Falcon, Becton Dickinson, NJ, USA) was placed on
top to prevent floating, and then culture of the sheets was
continued for 1 week to obtain firm and perfect integra-
tion of the cells in the multilayer chondrocyte sheets.
Scanning electron microscopy evaluation
Triple-layered chondrocyte cell sheets were soaked in 0.1
mol/l phosphate buffer and 2% glutaraldehyde for 2 h.
Next, the samples were fixed in 1% osmium solution for
1 h and dehydrated in ascending concentrations of etha-
nol (50%, 70%, 80%, 90%, 95%, and 100%). The speci-
mens were dried using the critical point drying method,
spatter-coated with gold, and affixed to an adhesive inter-
face for observation by SEM (JSM-840; Jeol Ltd., Tokyo,
Japan). Both the top and bottom surfaces of the cell sheets
were observed.
RNA isolation and cDNA synthesis
Total RNA extraction was carried out using the RNeasy
Mini kit (Qiagen Inc., Valencia, CA) according to the man-
ufacturer's instructions. RNA quality from each sample
was determined using the A260/280 absorbance ratio and
by electrophoresis on 1.2% agarose formaldehyde gel.
Total RNA (1.0–2.0 μg) was reverse transcribed into single
stand cDNA using MuLV reverse transcriptase (Applied
Biosystems, Foster City, CA, USA). The reverse-transcrip-
tion reaction was performed in a thermocycler at 42°C for
60 min and then at 95°C for 5 min.
Primer design and real-time PCR
All oligonucleotide primer sets were designed based upon
published mRNA sequences. The expected ampliconBMC Biotechnology 2009, 9:17 http://www.biomedcentral.com/1472-6750/9/17
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lengths ranged from 70 to 200 bp. The oligonucleotide
primers used in this study are listed in Table 1. The real-
time PCR was performed in a SmartCycler™ (Cepheid,
Sunnyvale, CA, USA) using SYBR Green PCR Master Mix
(Applied Biosystems). From 2 to 2.5 μl of cDNA template
was used for real-time PCR in a final volume of 25 μl.
cDNA was amplified according to the following condi-
tion: 95°C for 15 s and 60°C for 60 s from 35 to 45 ampli-
fication cycles. Fluorescence changes were monitored with
SYBR Green after every cycle. A melting curve analysis was
performed (a 0.5°C/s increase from 55 to 95°C with con-
tinuous fluorescence readings) at the end of cycles to
ensure that single PCR products were obtained. The
amplicon size and reaction specificity were confirmed by
2.5% agarose gel electrophoresis. All reactions were
repeated in six separate PCR runs using RNA isolated from
four sets of human samples. The results were evaluated
using the SmartCycler™ software program. Glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) primers
were used to normalize samples. To monitor crossover
contaminations of PCR, RNase-free water (Qiagen Inc)
was included in the RNA extraction and was used as a neg-
ative control. To ensure the quality of the data, a negative
control was always included in each run.
Immunohistochemical staining
Frozen sections (30 × 24 × 5 mm) of triple-layered cell
sheets were prepared using OCT compound (Sakura Fine
Technical Co., Tokyo, Japan). The sections were then
washed in PBS, and were reacted at room temperature for
60 min with three monoclonal antibodies: an anti-
fibronectin mouse monoclonal antibody (clone FBN11,
diluted 1:500, #MS-1351-P0; Thermo SCIENTIFIC, Lab
Vision Co., CA, USA), an anti-human CD11c (integrin
α10) mouse monoclonal antibody (clone BU15, diluted
1:200, #SM1834PS; Acris Antibodies GmbH, Herford,
Germany), and an anti-human collagen type 2 mouse
monoclonal antibody (clone α-4C11, diluted to 5 μg/ml,
#F-57; Daiichi Fine Chemical Co., Toyama, Japan). The
sections were washed in PBS, and reacted with polyclonal
rabbit anti-mouse immunoglobulin/FITC, diluted 1:100
(#F0261; DAKOcytomation, Glostrop, Denmark) as a flu-
orescent secondary antibody. Mounting with a water-sol-
uble mounting medium (VECTASHIELD®  Mounting
Medium with DAPI, Vector Laboratories, Inc., Burlin-
game, CA, USA) was performed to counterstain DNA after
washing sections in purified water.
Statistical analysis
The real-time PCR results are expressed as the mean ±
standard error of the mean from six determinations and
representative results are shown. The statistical software
program SPSS (Version 17.0, SPSS, Chicago, IL, USA) was
used to perform standard analysis of variance and the
Scheffe's post hoc test. Table 2 lists the p-values shown in
Figure 3.
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